HSGX 1,00$ (-64%)
| eröffnet am: | 05.09.18 16:22 von: | Vassago |
| neuester Beitrag: | 25.04.21 03:00 von: | Johannajjyma |
| Anzahl Beiträge: | 85 | |
| Leser gesamt: | 25600 | |
| davon Heute: | 5 | |
bewertet mit 3 Sternen |
||
|
Seite:
1
|
||
- MK 29 Mio. $
- Cash 9 Mio. $
- negatives EK
- lohnt nicht
https://www.massdevice.com/...es-on-missed-endpoint-in-neocart-trial/
chart_intraday_histogenics.png (verkleinert auf 33%)
mal sehen was nachher wieder geht bis morgen
jetzt aktuell nachbörslich bei 0,75 $
mehr Infos in der Gruppe
nmM
schau mer mal
diesmal werde ich wohl halten und wrten bis wieder weit über 1 $
nmM
Kapitalerhöhung im Anmarsch
http://ir.histogenics.com/...77&p=irol-newsArticle&ID=2370348
17 Mio. $ Offering
"WALTHAM, Mass., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation, a leader in the development of restorative cell therapies, today announced the pricing of an underwritten public offering of 26,155,000 shares of its common stock and warrants to purchase up to 19,616,250 shares of common stock, at a combined purchase price of $0.65 per share of common stock and accompanying warrant. The gross proceeds to Histogenics from this offering are expected to be $17.0 million, before deducting underwriting discounts and commissions, and offering expenses payable by Histogenics. The warrants are exercisable immediately upon issuance at a price of $0.70 per share of common stock and have a term of five years commencing on the date of issuance. The offering is expected to close on or about October 10, 2018, subject to customary closing conditions."
http://ir.histogenics.com/...77&p=irol-newsArticle&ID=2370442
- MK 27 Mio. $
- Cash 5 Mio. $
- Cash-burn ~ 7 Mio. in Q3
- Finger weg!
http://ir.histogenics.com/news-releases/...ird-quarter-2018-financial
FDA fordert eine zusätzliche klinische Studie
- MK 7,5 Mio. $
- Finger weg!
http://ir.histogenics.com/news-releases/...ussions-regarding-neocartr
https://www.nasdaq.com/de/symbol/hsgx/real-time
https://stocktwits.com/symbol/HSGX